These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3982574)

  • 1. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
    Brown EA; Markandu N; Sagnella GA; Jones BE; MacGregor GA
    Nephron; 1985; 39(4):290-5. PubMed ID: 3982574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the sodium retention in nephrotic syndrome.
    Usberti M; Gazzotti RM; Poiesi C; D'Avanzo L; Ghielmi S
    Am J Nephrol; 1995; 15(1):38-47. PubMed ID: 7872363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome?
    Brown EA; Markandu ND; Roulston JE; Jones BE; Squires M; MacGregor GA
    Nephron; 1982; 32(2):102-7. PubMed ID: 6757778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
    Brown EA; Markandu ND; Sagnella GA; Squires M; Jones BE; MacGregor GA
    Lancet; 1982 Dec; 2(8310):1237-40. PubMed ID: 6128546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-induced hypertension in patients with nephrotic syndrome.
    Klepikov PV; Kutyrina IM; Tareyeva IE
    Nephron; 1988; 48(4):286-90. PubMed ID: 3283584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of captopril on the sodium retention of the nephrotic syndrome.
    Brown EA; Markandu ND; Sagnella GA; Jones BE; MacGregor GA
    Nephron; 1984; 37(1):43-8. PubMed ID: 6371561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling.
    Meltzer JI; Keim HJ; Laragh JH; Sealey JE; Jan KM; Chien S
    Ann Intern Med; 1979 Nov; 91(5):688-96. PubMed ID: 496101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept.
    Dorhout Mees EJ; Geers AB; Koomans HA
    Nephron; 1984; 36(4):201-11. PubMed ID: 6369161
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome.
    Koomans HA; Geers AB; vd Meiracker AH; Roos JC; Boer P; Dorhout Mees EJ
    Am J Nephrol; 1984; 4(4):227-34. PubMed ID: 6383042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional relationships in the nephrotic syndrome.
    Geers AB; Koomans HA; Roos JC; Boer P; Dorhout Mees EJ
    Kidney Int; 1984 Sep; 26(3):324-30. PubMed ID: 6392692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine kallikrein excretion in relation to renal sodium handling in minimal change nephrotic syndrome.
    Ueda N; Niinomi Y; Nonoda T
    Clin Nephrol; 1991 Nov; 36(5):228-33. PubMed ID: 1752072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sodium retention in the nephrotic syndrome.
    Firth JD; Ledingham JG
    Aust N Z J Med; 1991 Dec; 21(6):893-901. PubMed ID: 1818554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of renin angiotensin aldosterone on minimal change nephrotic syndrome.
    Kumagai H; Onoyama K; Iseki K; Omae T
    Clin Nephrol; 1985 May; 23(5):229-35. PubMed ID: 4006331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iso-oncotic volume expansion in the nephrotic syndrome.
    Rabelink TJ; Bijlsma JA; Koomans HA
    Clin Sci (Lond); 1993 Jun; 84(6):627-32. PubMed ID: 8334809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
    Minutolo R; Andreucci M; Balletta MM; Russo D
    Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of vasopressin in edematous disorders.
    Schrier RW; Howard RL
    Nihon Naibunpi Gakkai Zasshi; 1989 Dec; 65(12):1311-27. PubMed ID: 2697604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edema formation in the nephrotic syndrome.
    Dorhout Mees EJ
    Contrib Nephrol; 1984; 43():64-75. PubMed ID: 6386329
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin-angiotensin-aldosterone system in nephrotic syndrome.
    Hammond TG; Whitworth JA; Saines D; Thatcher R; Andrews J; Kincaid-Smith P
    Am J Kidney Dis; 1984 Jul; 4(1):18-23. PubMed ID: 6377881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial natriuretic peptide in children with nephrotic syndrome].
    Jovanovitsh O; Popovitsh-Rolovitsh M; Radoshevitsh P; Stankovitsh R; Dujitsh A; Gajitsh M; Peco-Antitsh A; Krushchitsh D; Kostitsh M
    Srp Arh Celok Lek; 1995; 123(11-12):291-4. PubMed ID: 16296241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.